Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: a secondary analysis of the CREDENCE randomized trial

Citation
Jardine MJ, Zhou Z, Mahaffey KW, et al. J Am Soc Nephrol 2020;31:1128–39.